Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,596 | 1,649 | 95.6% |
| Travel and Lodging | $792.54 | 5 | 3.7% |
| Education | $150.88 | 7 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,767 | 204 | $0 (2024) |
| PFIZER INC. | $2,085 | 196 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,069 | 91 | $0 (2024) |
| Novo Nordisk Inc | $1,637 | 188 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,283 | 113 | $0 (2024) |
| Amgen Inc. | $1,266 | 104 | $0 (2024) |
| Lilly USA, LLC | $807.42 | 74 | $0 (2024) |
| Intuitive Surgical, Inc. | $792.54 | 5 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $691.94 | 55 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $676.41 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,204 | 257 | ABBVIE INC. ($532.36) |
| 2023 | $4,214 | 229 | ABBVIE INC. ($1,074) |
| 2022 | $2,506 | 194 | ABBVIE INC. ($591.92) |
| 2021 | $2,789 | 249 | AbbVie Inc. ($511.71) |
| 2020 | $2,004 | 176 | AstraZeneca Pharmaceuticals LP ($202.84) |
| 2019 | $2,207 | 182 | Novo Nordisk Inc ($322.30) |
| 2018 | $2,306 | 189 | PFIZER INC. ($422.74) |
| 2017 | $2,310 | 185 | PFIZER INC. ($514.47) |
All Payment Transactions
1,661 individual payment records from CMS Open Payments — Page 1 of 67
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: VACCINES | ||||||
| 12/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.20 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $0.32 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $30.50 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: PAIN | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: PAIN | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.54 | General |
| Category: PAIN | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.37 | General |
| Category: PAIN | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.32 | General |
| Category: PAIN | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Respiratory | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $2.98 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.82 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,971 | 5,446 | $512,732 | $231,338 |
| 2022 | 42 | 2,791 | 4,854 | $364,724 | $200,569 |
| 2021 | 37 | 2,552 | 4,475 | $329,605 | $178,598 |
| 2020 | 44 | 2,710 | 4,662 | $367,114 | $178,395 |
All Medicare Procedures & Services
157 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 543 | 1,601 | $149,694 | $88,878 | 59.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 317 | 577 | $79,338 | $49,245 | 62.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 208 | 208 | $29,120 | $25,117 | 86.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 64 | 64 | $11,968 | $10,061 | 84.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 132 | 133 | $11,633 | $9,563 | 82.2% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 38 | 38 | $10,450 | $6,779 | 64.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 90 | 140 | $20,967 | $6,304 | 30.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 96 | 110 | $8,800 | $4,339 | 49.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 33 | 34 | $9,350 | $3,212 | 34.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 38 | 38 | $12,540 | $3,156 | 25.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 41 | 86 | $4,730 | $2,811 | 59.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $3,080 | $2,507 | 81.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 82 | 82 | $2,952 | $2,408 | 81.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 16 | $3,344 | $1,943 | 58.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 111 | 201 | $104,053 | $1,875 | 1.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 83 | 109 | $3,706 | $1,735 | 46.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 48 | 48 | $6,000 | $1,690 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $4,180 | $1,662 | 39.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 111 | 124 | $10,912 | $1,160 | 10.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 45 | 50 | $5,225 | $1,103 | 21.1% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 122 | 165 | $1,860 | $990.33 | 53.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 122 | 165 | $1,860 | $823.44 | 44.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 91 | 138 | $1,540 | $792.02 | 51.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 24 | 185 | $3,053 | $733.80 | 24.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 192 | 290 | $1,595 | $627.42 | 39.3% |
About Dr. Robert Naples, DO
Dr. Robert Naples, DO is a Family Medicine healthcare provider based in Cortland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275506545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Naples, DO has received a total of $21,540 in payments from pharmaceutical and medical device companies, with $3,204 received in 2024. These payments were reported across 1,661 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($20,596).
As a Medicare-enrolled provider, Naples has provided services to 11,024 Medicare beneficiaries, totaling 19,437 services with total Medicare billing of $788,901. Data is available for 4 years (2020–2023), covering 157 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cortland, OH
- Active Since 02/08/2006
- Last Updated 06/15/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275506545
Products in Payments
- VRAYLAR (Drug) $1,468
- UBRELVY (Drug) $892.59
- Da Vinci Surgical System (Device) $792.54
- TRELEGY ELLIPTA (Drug) $734.83
- Ozempic (Drug) $719.58
- Kerendia (Drug) $676.41
- FARXIGA (Drug) $667.69
- XIFAXAN (Drug) $625.08
- ELIQUIS (Drug) $624.07
- BREZTRI (Drug) $585.66
- Otezla (Drug) $523.97
- CHANTIX (Drug) $521.48
- Vascepa (Drug) $513.89
- NURTEC ODT (Drug) $462.58
- EUCRISA (Drug) $445.07
- QULIPTA (Drug) $405.97
- ENTRESTO (Drug) $354.24
- TRADJENTA (Drug) $335.60
- JANUVIA (Drug) $327.88
- XARELTO (Drug) $281.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cortland
Dr. Robert Naples, D.o, D.O
Family Medicine — Payments: $17,565
Ruth Quarles, M.d, M.D
Family Medicine — Payments: $2,902
David Ouyang, M.d, M.D
Family Medicine — Payments: $2,351
Dr. Robert Castellanos, M.d, M.D
Family Medicine — Payments: $1,988
Mrs. Allison Orndorff, Msn, Crnp, Np-C, MSN, CRNP, NP-C
Family Medicine — Payments: $1,982
Alexander Langley, Md, MD
Family Medicine — Payments: $1,372